Biotech dealmaking accelerated heading into the JPM 2026 Healthcare Conference as large drugmakers face looming patent cliffs ...

Humacyte is cutting about a quarter of its workforce as it revamps its commercial strategy. Durham biotech's breakthrough ...

CNS Pharmaceuticals (NASDAQ:CNSP) is back on every biotech watchlist after a 242.36% one-week ramp tied to its Berubicin ...

Inovio Pharmaceuticals and Novavax stocks pare back earlier gains as the rally loses enthusiasm. Following a robust rally, Moderna appears to be regaining leadership within the biotech space. This ...

Yenssen Biotech opens international distributor recruitment for Dermlin wound healing series, Ulceloocin oral ulcer ...

This clinical-stage biotech develops bifunctional antibody therapies targeting solid tumors for oncology providers and ...

Kyle Diamantas, the acting commissioner of the FDA, is expected to be a drama-free, stabilizing caretaker at the top of the ...

MBC BioLabs sees its two biotech incubators location in San Francisco's Dogpatch neighborhood, near the AI hub of Mission Bay, as an advantage. It wants to build one more to prove the point.

Dr. Andrew Snyder (Monash University) joins the show to discuss the current biotech landscape: rising M&A and IPO activity, ...

Top 10 mid-cap stocks by YTD performance amid market volatility—see 600%+ gainers across semis, biotech & more, plus mid-cap ...

Legend Biotech Corp LEGN reported downbeat results for the first quarter on Tuesday. The company posted quarterly losses of 3 ...